Back to Capital International Investors Capital International Investors

XENEXENE

Showing 8 of 31 quarters

Position history for Capital International InvestorsCapital International Investors's holdings in Xenon Pharmaceuticals Inc.

Yes. Capital International Investors holds 2,361,639 shares of XENE (Xenon Pharmaceuticals), worth $142.5M, as of its Q2 2026 13F filing. It reduced the position by 313,088 shares (-11.7%) from Q1 2026. Capital International Investors has held XENE in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$142.5M

Current Shares

2.4M

Total Value Change

+$40.9M

Total Shares Change

-219,533

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.4M
-11.7%
$142.5M0.0%$60.36
0
2026-Q1
Decreased
2.7M
-21.7%
$155.5M0.0%$43.79
0
2025-Q4
Increased
3.4M
+7.3%
$153.1M0.0%$44.12
33
2025-Q3
Decreased
3.2M
0.0%
$127.7M0.0%$39.06
0
2025-Q2
Increased
3.2M
+3.0%
$99.6M0.0%$32.40
31
2025-Q1
Increased
3.1M
+21.3%
$103.6M0.0%$34.26
36
2024-Q4
Decreased
2.5M
-1.3%
$99.9M0.0%$38.53
0
2024-Q3
Increased
2.6M
+4.3%
$101.6M0.0%$38.65
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used